Meeting Banner
Abstract #3040

Multiparameteric Response Assessment of Hepatocellular Carcinoma Treated with Transarterial Chemoembolization Predicts Patient Survival Times

Susanne Bonekamp1, Zhen Li2, Vivek Gowdra Halappa1, Celia Pamela Corona-Villalobos1, Jean-Francois H. Geschwind1, Ihab R. Kamel1

1Radiology, Johns Hopkins University, Baltimore, MD, United States; 2Radiology, Tongji Medical College, Wuhan, China

Patient survival is the gold standard for the assessment of treatment response. The purpose of this study was to evaluate if early multiparametric assessment of treatment response is associate with patient survival in patients with hepatocellular carcinoma (HCC). To this end, HCC index lesions were analyzed using proprietary software and response was assessed based on change in tumor size as well as changes in volumetric ADC, hepatic arterial enhancement and portal venous enhancement. The combination of early change in portal venous enhancement and ADC more consistently predicted survival times than a single measurement or change in tumor size.

Keywords

ability accuracy analyses analyzed array arterial assess assessed assessment association automatically background bandwidth better breath cancer carcinoma category characteristic china clear clinical coil college combination confidence considered contrast corona criteria decrease developed diameter diffusion discriminate discriminating discrimination disease enhanced enhancement evaluated evaluation field functional furthermore generated gradient hazard hazards hepatic hold hypothesis improve included indeterminate index inst interactive interval intravenous jean johns lesions liver male matrix median medical model models month months multivariate natl optimal overall patient patients people perfect portal predict predicts primary prognostic proportional proprietary protocol radiology received represents republic responder response retrospectively scanner seed segmented slice software solid solutions spoiled standardized stat station statistical statistically status substantially suggest suppressed survival table therapy together torso treated treatment tumor tumors underwent univariate venous version view volumetric weeks whether years